Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Neptunus to Raise $219 Million for New Facilities

publication date: Feb 18, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shenzhen Neptunus Bioengineering released plans to raise up to 1.44 billion RMB ($219 million) through a private placement. The company expects to sell as much as 139 million shares at a minimum price of 10.37 RMB per share. Most of the new capital will be used to upgrade its distribution network. More details....

Stock Symbol: (SHE: 000078)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...